Symrise to sell AmeriTerpenes business to Mutares
Symrise said it will divest AmeriTerpenes, its American terpene-ingredients maker, to private-equity firm Mutares for an undisclosed sum.
Symrise has modestly improved its business portfolio by offloading its American terpene-ingredients maker, Mwb Research's Abed Jarad writes in a note to clients.
The German ingredients group said Tuesday the divestment of AmeriTerpenes to private-equity firm Mutares, for an undisclosed sum, will sh…